{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:47:13Z","timestamp":1793040433571,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jhep.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T22:18:16Z","timestamp":1534803496000},"page":"1317-1325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine"],"prefix":"10.1016","volume":"69","author":[{"given":"Robert John","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Theresa","family":"Cirulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiezhun","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ostrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiman","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga","family":"Chalasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Brent","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Hoofnagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2018.08.004_b0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1572-0241.1998.00459.x","article-title":"Terbinafine hepatotoxicity: case report and review of the literature","volume":"93","author":"Fernandes","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.004_b0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx0002029","article-title":"Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity","volume":"14","author":"Iverson","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jhep.2018.08.004_b0015","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0002-9343(02)01109-9","article-title":"Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis","volume":"112","author":"Anania","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2018.08.004_b0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/lt.21034","article-title":"Terbinafine-induced hepatic failure requiring liver transplantation","volume":"13","author":"Perveze","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2018.08.004_b0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","article-title":"Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct","volume":"32","author":"Fontana","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2018.08.004_b0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1053\/j.gastro.2011.04.001","article-title":"Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA Class I and II alleles","volume":"141","author":"Lucena","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.004_b0035","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"Association of liver injury from specific drugs, or groups of drugs, with polymorphisms in HLA and other genes in a genome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.004_b0040","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.004_b0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","article-title":"Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6\u202fmonths from onset","volume":"147","author":"Fontana","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.004_b0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2018.08.004_b0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2018.08.004_b0060","doi-asserted-by":"crossref","first-page":"D784","DOI":"10.1093\/nar\/gku1166","article-title":"Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations","volume":"43","author":"Gonzalez-Galarza","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2018.08.004_b0065","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.humimm.2013.06.025","article-title":"Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry","volume":"74","author":"Gragert","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0070","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.humimm.2009.08.006","article-title":"Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning","volume":"70","author":"Schmidt","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.humimm.2012.10.029","article-title":"High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: how can they be used to improve unrelated donor searches?","volume":"74","author":"Pingel","year":"2013","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humimm.2003.10.004","article-title":"High resolution HLA-DRB1 identification of a Caucasian population","volume":"65","author":"Williams","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0085","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.humimm.2016.09.004","article-title":"High-resolution HLA A\u223cB\u223cDRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel","volume":"77","author":"Manor","year":"2016","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nprot.2008.197","article-title":"Protein structure homology modeling using SWISS-MODEL workspace","volume":"4","author":"Bordolo","year":"2009","journal-title":"Nat Protoc"},{"key":"10.1016\/j.jhep.2018.08.004_b0095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molimm.2011.08.015","article-title":"Structural basis of cross-allele presentation by HLA-A*0301 and HLA-A*1101 revealed by two HIV-derived peptide complexes","volume":"49","author":"Zhang","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jhep.2018.08.004_b0100","doi-asserted-by":"crossref","first-page":"29784","DOI":"10.1074\/jbc.M109.038497","article-title":"Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens","volume":"284","author":"Kumar","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2018.08.004_b0105","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.jhep.2018.08.004_b0110","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.1016\/j.jhep.2018.08.004_b0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/ci00057a005","article-title":"SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules","volume":"28","author":"Weininger","year":"1988","journal-title":"J Chem Inf Comput Sci"},{"key":"10.1016\/j.jhep.2018.08.004_b0120","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2018.08.004_b0125","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4254\/wjh.v6.i8.601","article-title":"Assessing liver injury associated with antimycotics: concise literature review and clues from data mining of the FAERS database","volume":"6","author":"Raschi","year":"2014","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jhep.2018.08.004_b0130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ijantimicag.2013.07.004","article-title":"Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight","volume":"42","author":"Adriaenssens","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jhep.2018.08.004_b0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/bcp.12178","article-title":"Risk of oral antifungal agent-induced liver injury in Taiwanese","volume":"77","author":"Kao","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2018.08.004_b0140","first-page":"299","article-title":"Safety and tolerability of oral antifungal agents in the treatment of fungal nail disease: a proven reality","volume":"1","author":"Elewski","year":"2005","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jhep.2018.08.004_b0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1046\/j.1365-2125.1999.00095.x","article-title":"A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs","volume":"48","author":"Garcia Rodriguez","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jhep.2018.08.004_b0150","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ajg.2015.283","article-title":"Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury","volume":"110","author":"Fontana","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2018.08.004_b0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11096-014-9969-y","article-title":"Systematic review of severe acute liver injury caused by terbinafine","volume":"36","author":"Yang","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.jhep.2018.08.004_b0160","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1023\/A:1018870828038","article-title":"Terbinafine-induced prolonged cholestasis with reduction of interlobular bile ducts","volume":"42","author":"Mallat","year":"1997","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2018.08.004_b0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cgh.2016.05.043","article-title":"Features of autoimmune hepatitis in patients with Drug-induced liver injury","volume":"15","author":"DeBoer","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2018.08.004_b0170","unstructured":"US Census 2010; http:\/\/www.census.gov\/prod\/cen2010\/briefs\/c2010br-11.pdf."},{"key":"10.1016\/j.jhep.2018.08.004_b0175","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1073\/pnas.1207934109","article-title":"Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire","volume":"109","author":"Ostrov","year":"2012","journal-title":"PNAS"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818322839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827818322839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:34:19Z","timestamp":1759174459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827818322839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0168827818322839"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2018.08.004","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}